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distributions calculated in Eclipse TPS; for the evaluation of 
pre-treatment verification agreement, D100% , DMean and D1% and 
local γ analysis (2mm/2% - 3mm/3%) were investigated for 
CTV, PTV and OARs. The same cases were analyzed, in terms 
of γ analysis (2mm/2% - 3mm/3%) with our routinely pre-
treatment verification system, based on EPID images and 
EPIQA software. Finally to test systems robustness, 
intentional errors have been introduced to the original 
position for one of the SBRT plans, in a first step closing the 
X1 jaw, then opening a single leaf. 
Results: Average differences, between Eclipse TPS and 
Compass reconstruction, in terms of D100% , DMean and D1% for 
PTV result, respectively, 3.0 %, 1.9 %, 2.1 % for liver, 1.9 %, 
1.1 % and 2.1 % for brain, 13 %, 4.2 % and 1.8 % for lung. 
Fig. 1 shows the worst scenario found in terms of differences 
between calculated and measured dose distribution; in this 
case local γ test fails for PTV and CTV (86,5 % and 82 %): it's 
due to a difference of +4 % in absolute dose inside the CTV. 
Even if this result could be not acceptable with conventional 
pre-treatment verification devices, the chance to investigate 
about dose differences inside the target and OAR, could be 
really interesting from a clinical point of view. For the same 
case the number of point with γ<1, found with EPIQA, is 96 %. 
 
 
Fig. 1 
Tab. 1 shows detected errors with two systems in terms of 
differences in D100% and D50%, respect to the reference correct 
plan. 
 
Tab. 1 
 
Conclusions: This work confirms that gamma approach for 
pre-treatment verifications could be not enough sensitive to 
decide about delivery. A system like Compass gives more 
completed information in terms of 3D dose distribution and 
DVH taking into account patients anatomy; it seems to be 
also capable to detect possible errors. 
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Purpose/Objective: The purpose of EPID in vivo dosimetry is 
to verify whether the predicted and delivered dose agree, 
both in terms of absolute dose and geometrical deposition. 
Dedicated software, the in vivo 3D DC (Dosimetry Check) 
system (Math Resolutions, Columbia), was implemented at 
our hospital to replace our pretreatment D4 (Delta4) system 
(Scandidos, Uppsala). 
Materials and Methods: Math Resolutions was provided with 
output factors and dose profiles to model the dose kernels 
for our linear accelerators. Deconvolution kernels were 
created by measuring transit dose with the linac specific EPID 
panel for different field sizes at different thicknesses of 
water. The DC software handles 2 modes of operation. For 
transit dosimetry, the patient attenuated fluence is acquired 
during clinical treatment. For pretreatment dosimetry, the 
un-attenuated fluence is acquired. The main limiting factor 
of the system is the size of the sensitive region of the EPID 
panel (30x40 cm2 for Varian and 41x41 cm2 for Elekta). Since 
the height of the Varian EPID panel is variable, treatment 
plans with a larger field size can be measured as a 
pretreatment plan at a smaller SID. 
Results: A tissue-equivalent polystyrene CarPet phantom of 
20 cm thickness was used for the validation of the DC system. 
An agreement within 5% of the isocentric treatment plan 
dose was obtained for every clinically used combination of 
TPS and linac. Gamma criteria of 3mm/3% with pass/fail 
criteria of 95% for fixed-beam IMRT and 90% for VMAT have 
been used at our department for measurements on the 
presumed homogeneous D4 phantom. For pretreatment DC 
dosimetry, relaxed gamma criteria of 3mm/6% were applied 
since the dose is reconstructed on the heterogeneous CT-
based model of the patient. Taking into account setup errors 
inaccuracies and patient anatomy uncertainties, gamma 
criteria of 5mm/6% were used for transit DC dosimetry. For 
both systems, a threshold of 20% of the prescribed dose was 
applied to exclude false positive influences of low dose 
regions. For lung cases, the pencil beam algorithm used in DC 
did not meet our requirements for accurate dose 
reconstruction. Therefore, we applied a density override in 
the patient lung region in both dose planning and DC dose 
reconstruction of pretreatment measurements. Primary test 
results suggest a better congruence with D4 γ results and 
with the acceptance isocentre dose difference (DD) 
specifications (overview in Table 1). 
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Table 1. Comparison of D4 γ results, DC γ and DC DD for lung 
plans with and without density override (DO) in the body or 
lung volume. 
 
Conclusions: The DC EPID in vivo dosimetry system was 
successfully implemented at our hospital. Corresponding 
gamma pass/fail criteria for DC and D4 phantom 
measurements were established. A solution was found to 
overcome dose reconstruction issues in strong heterogeneous 
regions. The main limitation of the system remains the size 
of the EPID panel.  
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Purpose/Objective: The new commercial thermal neutron 
device (TNRD) has a good response with directionality in a 
pure neutron beam [1]. In addition, good coincidence with 
TLD detectors was found for peripheral neutron dose 
estimation in-phantom [2]. Nevertheless, further experiments 
have shown that TNRD is not completely reliable in some 
special clinical conditions, due to photon contribution. The 
aim of this work is the knowledge of uncertainties related to 
photon presence under different irradiation conditions, 
especially angle incidence influences at different field-edge 
distances. This will not only verify the goodness of TNRD 
measurements due to a possible compensation, but to find a 
possible correction to improve peripheral neutron doses 
estimation.  
Materials and Methods: TNRD detector is based on a pair of 
commercial photodiodes, and allows the measurement of 
thermal neutron fluences under an intense photon 
background [1]. However in the case of an in important 
photon presence, intrinsic differences among diodes make 
TNRD signal to be over or underestimated, due to their 
relative position with respect to the beam incidence. This 
could be a consequence of 'shadow' effect, from one diode to 
the other, as the reading is obtained by the subtraction of 
both signals (the one of the sensitized to neutrons and the 
normal one). Six gantry angle incidences (0º, 45º, 135º, 180º, 
225º and 315º) were measured in 6 and 15 MV for two 
different field-edge detector distances (10 and 25 cm, 
corresponding to an approx. dose rate 3.53 and 1.21 
cGy/min). A Primus Siemens linac using a 40x10 cm2 field was 
employed with TNRD detectors inserted in the middle of two 
layers of 4 cm polyethylene. 
Results: The table shows TNRD readings at 6 MV (photon 
signal) and neutron component from 15 MV (subtraction of 15 
MV and 6 MV readings). Photon influence in TNRD neutron 
readings are up to 50% for 315º and 135º for 10 cm. However 
if we consider the accumulated readings among the whole 
arc, total photon component is compensated and reduced to 
9.3% or 6.7% depending on distance to field-edge. The figure 
shows the compensation of photon component for 
complementary gantry angles. 
 
Table. (see text) 
 
 
Figure. TNRD readings for complementary gantry angles at a 
field-edge detector distance of 10 (dashed line) and 25 (solid 
line) cm.  
Conclusions: Results obtained here explain the problem that 
TNRD measurements have shown when measuring at some 
angle incidences at different distances to the field-edge 
because of photon contribution. The good relation obtained 
with TLD detectors in previous experiences [2] are due to the 
compensation of different angle incidences shown here. 
lthough good measurements are obtained when compensated 
multi-incidences are used, more accurate results would be 
obtained if 6 and 15 MV measurements are performed under 
the same conditions. This would be relevant when non-
balanced gantry incidences are used.  
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